To address the issue of potential reduced uptake of Pap smears secondary to the vaccination.
This is a completely separate consideration and should have no bearing on if the vaccine is or is not given. IT is a weak argument against giving the vaccine as it has nothing to do with the vaccines efficacy or ability. It is about good sexual health education and ensuring that the decision to vaccinate is informed with good understanding of what the jab can and cant do. 'No one wants to go for a smear, its no fun.' Neither is going to the dentist, but we all need to take a degree of personal responsibility for our health.
I think on this one BB, this is your opinion but certainly doesn't add strong weight to an argument against the vaccine. It does not make the vaccine less effective or safe at what it states it can do.
As for your arguments about safety concerns. Vaccines are no different from any other medication. Their side effects and adverse incidents are reported in the same way as any other medication. The MHRA regulates all medicines very closely and drugs are withdrawn if they are considered not to be safe. There is no conspiracy theory here. There is extensive good quality evidence that clearly demonstrates this vaccines efficacy and safety.
I understand that as a parent you would demand answers if your child develops any health problems, not just post vaccination. Sometimes in medicine, we dont know why diseases happen or what triggers them. We do investigate as far as we are able and to say that an adverse event has or has not been caused by a vaccine or medicine is well within the scope and ability of the medial profession.
There are no increased risk of serious side effects with either jab. This is supported by good quality and a high volume of evidence.
As for the efficacy,the vaccine does not 'only last 6 years', this is misleading. The studies published are showing that patients who have been vaccinated have no signs of reduced immunity at 6.4 years, there is not evidence that immunity reduces after this time. The studied patients will continue to be followed up and research is ongoing to monitor the maintenance of immunity (estimated between 15-20 years)